Member Info for Tommy85

To see delayed trades from yesterday, come Monday T3 settlement.

And also just to note, this is people lives here guys!! Many here have been involved with someone who has had cancer of some form, maybe just maybe Val are onto something, time will tell. As described below additional life secured is priceless!

I liked this bit from the RNS, 401 was treated in Georgia on patients that had Stage IV NSCLC, very late stage, always wondered what would happen if 401 was used at a much earlier / beginning stage once diagnosed (pretty big news IMO) and the advisory board seem to agree!! :) ''The meeting was organised and executed by the independent communications company, Hayward Medical, who provided a report detailing the ideas and enthusiasm the participants showed for the development of VAL401 to date. In particular the need for a treatment that can be used to alleviate symptoms even in end-stage patients was highlighted and that the co-prescription of a drug to provide supportive benefits in addition to anti-cancer benefits would be valuable from the beginning of the patient journey, alongside currently used approaches. The participants' individual comments included that they would be confident taking VAL401 immediately on cancer diagnosis, alongside standard of care treatment; that every month of additional life secured is priceless, particularly with maintained quality, and in fact that, terminal patients often prefer to retain their Quality of Life than to risk further disruptive treatment''

http://www.lse.co.uk/sharecast-news-article.asp?ArticleCode=27559859&ArticleHeadline=AstraZenecas_Lynparza_improves_survival_in_advanced_prostate_cancer

And possibly the lowest volume traded in about 7 months.......so far that is

http://www.bbc.co.uk/news/health-44343415

The peer reviewed publication is taking longer than first thought!!

And also 201 on the value of docetaxel (Taxotere) or abiraterone acetate (Zytiga) in combination with androgen deprivation therapy (ADT) in prostate cancer. Quite recent, released on Monday 21st May - https://www.onclive.com/publications/oncology-live/2018/vol-19-no-11/study-findings-complicate-the-paradigm-for-hormonesensitive-prostate-cancer Begs the question could 201 be mixed with these types of drugs?

TBB - how about a comparable in the NSCLC market for 401 - Keytruda, could be a $16 billion asset by 2025 - https://www.investors.com/news/technology/merck-bristol-lung-cancer-battle/

Postman great post and fully agree :)

With one of the other 4 drugs being our lead compound 201, itching to see some results from the dose exclation after the mhra approved back in December, that with the wrap around of all of those patents granted :)

Think he loaded up prior to the December charge to 7.5p

I agree Tricky, was interesting that funding for 401 wasn’t mentioned in the placing rns yesterday which would lead to the bod being close to commercials on this!! Next week will be interesting, beautiful weather, enjoy the weekend all :)

Bloody hell nom, seem to put a lot of overtime into a share you’re not invested in!!

Hi mate, just a quick one i see your posting on here!! I have ntog in my portfolio and your involved in there aswell, anyway i digress from the point of me posting here. My uncle is a pilot for Thomson and he has been telling me for some time to get involved over here. They have just announced new flight destinations in thailand and told me today that him and his crew are being trained up currently on the new 787 dream liner which is being used for new flight destinations within the new year including mexico.........thought i would divulge such information. ATB :)

What is happening here?